Follow The Filings

CING Cingulate

Cingulate earnings company data as of 4:48 AM ET 10/23

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS -0.56 -0.45 Beat
Rev — — —

Insider trades

Open-market buys and sales by CING's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CING insider trades
  • $657K bought by 5 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Thomas Jeffrey Hargroves Director
    Buy
    $490K 97,276 shares at $5.04 +50665% to stake
    Traded Feb 13 Filed Jun 8
    ↗
  2. Peter J. Werth Director
    Buy
    $98K 19,455 shares at $5.04 +20% to stake
    Traded Feb 6 Filed Feb 10
    ↗
  3. Jennifer L. Callahan CFO
    Buy
    $25K 4,864 shares at $5.04 +2494% to stake
    Traded Feb 6 Filed Feb 10
    ↗
  4. Shane J. Schaffer CEO
    Buy
    $34K 6,809 shares at $5.04 +202% to stake
    Traded Feb 6 Filed Feb 10
    ↗
  5. Matthew Brams EVP and Chief Medical Officer
    Buy
    $9,808 1,946 shares at $5.04 +72% to stake
    Traded Feb 6 Filed Feb 10
    ↗

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants and 5 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
8-K 5.02 Filing Doc
424B3 Filing Doc
SCHEDULE 13D/A — Filing Doc
424B3 Filing Doc
8-K 1.01,5.07 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-K Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.